GAF AG – Trademark Portfolio
Entity Type: 25
GAF AG holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 7 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AGROCROP, AGROSOIL, and AGROYIELD.
Arnulfstr. 199
80634 München
Showing of trademarks Trademarks
Trademark Classifications
GAF AG's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does GAF AG have?
GAF AG has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does GAF AG file in?
GAF AG files trademarks across 7 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are GAF AG's most well-known trademarks?
GAF AG's registered trademark portfolio includes well-known marks such as AGROCROP, AGROSOIL, and AGROYIELD. These are among 3 currently registered trademarks in the portfolio.
What is GAF AG's trademark registration success rate?
GAF AG has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.